Stock Events

Stock Events

FluoroPharma Medical 

$0.000200
2
+$0.00+100%Monday 15:04

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0002
52W Low
0.0001
Volume
1,188,100
Avg. Volume
565
Mkt Cap
6,814.8
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 30Expected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

Financials

-Profit Margin
Unprofitable
2014
2015
0Revenue
-3.74MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GE HealthCare Technologies
GEHC
Mkt Cap29.04B
GE Healthcare competes in the medical imaging and diagnostics field, similar to FluoroPharma's focus on imaging agents for PET scans.
Shoulder Innovations
SI
Mkt Cap418.08M
Siemens Healthineers offers a range of imaging equipment and diagnostics solutions that overlap with FluoroPharma's PET imaging technologies.
Koninklijke Philips N.V.
PHG
Mkt Cap23.38B
Philips, through its healthcare division, provides imaging systems and healthcare solutions that compete in the same space as FluoroPharma.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific provides various healthcare solutions, including imaging technologies that can be seen as competitive to FluoroPharma's offerings.
Abbott Laboratories
ABT
Mkt Cap168.71B
Abbott Laboratories has a broad range of diagnostic and medical imaging products that compete with FluoroPharma's specialized imaging agents.
Danaher
DHR
Mkt Cap150.48B
Danaher, through its subsidiaries, produces medical imaging solutions and diagnostics that are in direct competition with FluoroPharma's products.
Bruker
BRKR
Mkt Cap9.64B
Bruker Corporation offers instruments and solutions for molecular and diagnostic imaging, competing in the same niche as FluoroPharma.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories provides products and services in the field of clinical diagnostics and imaging, relevant to FluoroPharma's market.
Medtronic
MDT
Mkt Cap110.49B
Medtronic, while primarily known for medical devices, also provides diagnostic and imaging technologies that compete with FluoroPharma's products.

About

FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical trial. This compound aims to evaluate myocardial blood flow and metabolism in individuals afflicted with CAD. FluoroPharma Medical has established key collaborations, including licensing agreements with Massachusetts General Hospital and Sinotau USA. Furthermore, the company holds clinical research agreements with Pharmaceutical Product Development, LLC, and Cardiovascular Imaging Technologies. Established in 2003, FluoroPharma Medical, Inc. is headquartered in Montclair, New Jersey.
Show More
CEO
Edward L. Lyons Jr.
Employees
4
Country
United States
ISIN
US3438701019

Listings

OTC Link
US
FPMI

0 Comments

Share your thoughts

FAQs

What is FluoroPharma Medical stock price today?▼
The current price of FPMI is $0.00 USD — it has increased by +100% in the past 24 hours. Watch FluoroPharma Medical stock price performance more closely on the chart.
What is FluoroPharma Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange FluoroPharma Medical stocks are traded under the ticker FPMI.
Is FluoroPharma Medical stock price growing?▼
FPMI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year FluoroPharma Medical has showed a +100% increase.
What is FluoroPharma Medical market cap?▼
Today FluoroPharma Medical has the market capitalization of 6,814.8
What were FluoroPharma Medical earnings last quarter?▼
FPMI earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is FluoroPharma Medical revenue for the last year?▼
FluoroPharma Medical revenue for the last year amounts to 0 USD.
What is FluoroPharma Medical net income for the last year?▼
FPMI net income for the last year is -3.74M USD.
How many employees does FluoroPharma Medical have?▼
As of November 1, 2026, the company has 4 employees.
In which sector is FluoroPharma Medical located?▼
FluoroPharma Medical operates in the Health & Wellness sector.
When did FluoroPharma Medical complete a stock split?▼
FluoroPharma Medical has not had any recent stock splits.
Where is FluoroPharma Medical headquartered?▼
FluoroPharma Medical is headquartered in Montclair, United States.